Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gresser

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Infectious Diseases|August 1, 1988
Penicillin tolerance in group A streptococciB F Woolfrey, R T Lally, M Gresser-Burns
The Journal of Biological Chemistry|November 10, 1979
Assessment of total catalytic sites and the nature of bound nucleotide participation in photophosphorylationG Rosen, M Gresser, C Vinkler, et al.
Annual Review of Biochemistry|January 1, 1994
5-LipoxygenaseA W Ford-Hutchinson, M Gresser, R N Young
The Journal of Biological Chemistry|November 10, 1979
Demonstration and quantitation of catalytic and noncatalytic bound ATP in submitochondrial particles during oxidative phosphorylationM Gresser, J Cardon, G Rosen, et al.
The Journal of Biological Chemistry|June 25, 1972
Acetyl coenzyme A: arylamine acetyltransferase. Measurement of the steady state concentration of the acetyl-enzyme intermediateW P Jencks, M Gresser, M S Valenzuela, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1987
Oxacillin killing curve patterns of Staphylococcus aureus isolates by agar dilution plate count methodB F Woolfrey, R T Lally, M N Ederer, et al.
Protein Expression and Purification|June 1, 1995
Purification of baculovirus-overexpressed cytosolic phospholipase A2 using a single-step affinity column chromatographyK M Abdullah, S Leger, H Perrier, et al.
Biochemistry|June 1, 2000
Conformational difference between PDE4 apoenzyme and holoenzymeF Laliberté, Y Han, A Govindarajan, et al.
British Journal of Pharmacology|May 1, 1997
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitorD Riendeau, M D Percival, S Boyce, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profilesC C Chan, S Boyce, C Brideau, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Infectious Diseases|August 1, 1988
Penicillin tolerance in group A streptococciB F Woolfrey, R T Lally, M Gresser-Burns
The Journal of Biological Chemistry|November 10, 1979
Assessment of total catalytic sites and the nature of bound nucleotide participation in photophosphorylationG Rosen, M Gresser, C Vinkler, et al.
Annual Review of Biochemistry|January 1, 1994
5-LipoxygenaseA W Ford-Hutchinson, M Gresser, R N Young
The Journal of Biological Chemistry|November 10, 1979
Demonstration and quantitation of catalytic and noncatalytic bound ATP in submitochondrial particles during oxidative phosphorylationM Gresser, J Cardon, G Rosen, et al.
The Journal of Biological Chemistry|June 25, 1972
Acetyl coenzyme A: arylamine acetyltransferase. Measurement of the steady state concentration of the acetyl-enzyme intermediateW P Jencks, M Gresser, M S Valenzuela, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1987
Oxacillin killing curve patterns of Staphylococcus aureus isolates by agar dilution plate count methodB F Woolfrey, R T Lally, M N Ederer, et al.
Protein Expression and Purification|June 1, 1995
Purification of baculovirus-overexpressed cytosolic phospholipase A2 using a single-step affinity column chromatographyK M Abdullah, S Leger, H Perrier, et al.
Biochemistry|June 1, 2000
Conformational difference between PDE4 apoenzyme and holoenzymeF Laliberté, Y Han, A Govindarajan, et al.
British Journal of Pharmacology|May 1, 1997
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitorD Riendeau, M D Percival, S Boyce, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profilesC C Chan, S Boyce, C Brideau, et al.
Pageof 2